Predictive Role of Biomarkers in COVID-19 Mortality

Ayşe Yılmaz,1 Öztürk Taşkın,1 Ufuk Demir,1 and Veysel G Soylu2 Cureus. 2023 Jan; 15(1): e34173. Published online 2023 Jan 24 doi: 10.7759/cureus.34173 PMCID: PMC9950690PMID: 36843833 Abstract Background The coronavirus disease 2019 (COVID-19) pandemic has resulted in high mortality among patients in critical intensive care units. Hence, identifying mortality markers in the follow-up and treatment of these patients is essential. This study aimed to evaluate […]

Top Doctor Explains Why “Turbo Cancer” Rates Are Likely to Get Even Worse

Sep. 14, 2023 10:15 am This article originally appeared on and was republished from Gateway “These cancers that normally would be kept in check by the body are unexpectedly growing very quickly.” “We know that the COVID vaccines have done various degrees of damage to the immune system in a fraction of people who’ve taken them,” attested Dr. Harvey […]

Conflicting Evidence Of mRNA Technology Raises Serious Concerns About Rush For Use In New Vaccine Development

Authored by Megan Redshaw via The Epoch Times, FRIDAY, SEP 01, 2023 The U.S. government and pharmaceutical companies are investing a substantial amount to develop new mRNA vaccines for infectious diseases and cancer, fueling a lucrative mRNA platform valued at $136.2 billion. A newly established White House program announced on Aug. 23 that it is granting a […]

Case Report of a Pro-Vaccine Researcher Suggests mRNA Vaccine Might Worsen Lymphoma Cancer

Authors:  Jim Hoft Published October 15, 2022 TGP Evidence of unexpected rapid progression of lymphomatous lesions was detected in a man recently diagnosed with angioimmunoblastic T-cell lymphoma (AITL) a rare, often but not always, aggressive (fast-growing) form of peripheral T-cell lymphoma, according to a case report analyzed by six health experts. Angioimmunoblastic T-cell lymphoma (AITL) is a type […]